Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Envista Holdings Corporation Common Stock (NY:NVST)

18.53 +0.53 (+2.94%)
Official Closing Price Updated: 4:10 PM EDT, May 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Envista Holdings Corporation Common Stock

< Previous 1 2 3 4 Next >
Beyond The Numbers: 7 Analysts Discuss Envista Holdings Stock
Via Benzinga
Planet Labs, Envista, and Lumen Stocks Trade Up, What You Need To Know
A number of stocks jumped in the morning session after the major indices rebounded (Nasdaq +2.0%, S&P 500 +1.5%) as President Trump postponed the planned 50% tariff on European Union imports, shifting... 
Via StockStory
Topics Artificial Intelligence Government Stocks
Exposures Artificial Intelligence Political Tariff
1 Surging Stock to Consider Right Now and 2 to Approach with Caution
Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or... 
Via StockStory
Envista, NeoGenomics, Acadia Healthcare, Astrana Health, and Hims & Hers Health Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after the major pulled back (Nasdaq -1.3%, S&P 500 - 1.4%) as Treasury yields rose, reflecting market anxiety over a draft federal budget that could... 
Via StockStory
Topics Bonds Stocks
Exposures Debt Markets US Equities
Earnings Scheduled For May 1, 2025
Via Benzinga
Envista Holdings Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
Via Benzinga
Envista Holdings Earnings Review: Q4 Summary
Via Benzinga
NVST Q1 Earnings Call: Resilient Revenue Amid Tariff Uncertainty and Margin Pressures
Dental products company Envista Holdings (NYSE:NVST) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, but sales fell by 1.1% year on year to $616.9 million. Its non-GAAP profit of... 
Via StockStory
Topics Economy World Trade
Exposures Interest Rates Tariff
Solventum, Envista, ICU Medical, Globus Medical, and Enovis Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides... 
Via StockStory
Topics Government Stocks World Trade
Exposures Political Tariff US Equities
Envista (NYSE:NVST) Surprises With Q1 Sales
Dental products company Envista Holdings (NYSE:NVST) beat Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 1.1% year on year to $616.9 million. Its non-GAAP profit of $0.24 per share... 
Via StockStory
Insights into Envista Holdings Q4 Earnings
Via Benzinga
Earnings Scheduled For February 5, 2025
Via Benzinga
5 Analysts Have This To Say About Envista Holdings
Via Benzinga
Demystifying Envista Holdings: Insights From 7 Analyst Reviews
Via Benzinga
Envista (NVST) To Report Earnings Tomorrow: Here Is What To Expect
Dental products company Envista Holdings (NYSE:NVST) will be announcing earnings results tomorrow after market close. Here’s what investors should know. 
Via StockStory
7 Analysts Have This To Say About Envista Holdings
Via Benzinga
Q4 Rundown: Dentsply Sirona (NASDAQ:XRAY) Vs Other Dental Equipment & Technology Stocks
Let’s dig into the relative performance of Dentsply Sirona (NASDAQ:XRAY) and its peers as we unravel the now-completed Q4 dental equipment & technology earnings season. 
Via StockStory
Envista (NVST): Buy, Sell, or Hold Post Q4 Earnings?
Over the last six months, Envista shares have sunk to $15.51, producing a disappointing 18.5% loss - worse than the S&P 500’s 8.1% drop. This was partly driven by its softer quarterly results and might... 
Via StockStory
Topics Stocks
Exposures US Equities
3 Cash-Producing Stocks with Questionable Fundamentals
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak... 
Via StockStory
Q4 Earnings Highs And Lows: Envista (NYSE:NVST) Vs The Rest Of The Dental Equipment & Technology Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Envista (NYSE:NVST) and the best and worst... 
Via StockStory
Dental Equipment & Technology Stocks Q4 Earnings Review: Align Technology (NASDAQ:ALGN) Shines
Let’s dig into the relative performance of Align Technology (NASDAQ:ALGN) and its peers as we unravel the now-completed Q4 dental equipment & technology earnings season. 
Via StockStory
Dental Equipment & Technology Stocks Q4 In Review: Henry Schein (NASDAQ:HSIC) Vs Peers
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Henry Schein (NASDAQ:HSIC) and the best and... 
Via StockStory
Earnings To Watch: Dentsply Sirona (XRAY) Reports Q4 Results Tomorrow
Dental products company Dentsply Sirona (NASDAQ:XRAY) will be announcing earnings results tomorrow morning. Here’s what you need to know. 
Via StockStory
Henry Schein (HSIC) Q4 Earnings Report Preview: What To Look For
Dental and Medical products company Henry Schein (NASDAQ:HSIC) will be reporting results tomorrow morning. Here’s what investors should know. 
Via StockStory
DEXIS Showcases Newest Technology at Chicago Midwinter and Lab Day Conferences
Via ACCESS Newswire
Edwards Lifesciences (EW) Reports Q4: Everything You Need To Know Ahead Of Earnings
Medical technology company Edwards Lifesciences (NYSE:EW) will be reporting results tomorrow after market close. Here’s what to look for. 
Via StockStory
Envista’s (NYSE:NVST) Q4 Sales Beat Estimates
Dental products company Envista Holdings (NYSE:NVST) announced better-than-expected revenue in Q4 CY2024, with sales up 1.1% year on year to $652.9 million. Its non-GAAP profit of $0.24 per share was... 
Via StockStory
Topics Earnings
Exposures Financial
What Does Dental Player Patterson's $4.1 Billion Deal Mean For Other Players?
Patient Square Capital agrees to buy Patterson Companies for $4.1 billion. Analysts predict minimal regulatory hurdles and a strong bid unlikely to face competition. 
Via Benzinga
This Wingstop Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.